Skip to main content
Journal cover image

Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study.

Publication ,  Journal Article
Schreiber, JE; Palmer, SL; Conklin, HM; Mabbott, DJ; Swain, MA; Bonner, MJ; Chapieski, ML; Huang, L; Zhang, H; Gajjar, A
Published in: Neuro Oncol
November 29, 2017

BACKGROUND: Patients treated for medulloblastoma who experience posterior fossa syndrome (PFS) demonstrate increased risk for neurocognitive impairment at one year post diagnosis. The aim of the study was to examine longitudinal trajectories of neuropsychological outcomes in patients who experienced PFS compared with patients who did not. METHODS: Participants were 36 patients (22 males) who experienced PFS and 36 comparison patients (21 males) who were matched on age at diagnosis and treatment exposure but did not experience PFS. All patients underwent serial evaluation of neurocognitive functioning spanning 1 to 5 years post diagnosis. RESULTS: The PFS group demonstrated lower estimated mean scores at 1, 3, and 5 years post diagnosis on measures of general intellectual ability, processing speed, broad attention, working memory, and spatial relations compared with the non-PFS group. The PFS group exhibited estimated mean scores that were at least one standard deviation below the mean for intellectual ability, processing speed, and broad attention across all time points and for working memory by 5 years post diagnosis. Processing speed was stable over time. Attention and working memory declined over time. Despite some change over time, caregiver ratings of executive function and behavior problem symptoms remained within the average range. CONCLUSION: Compared with patients who do not experience PFS, patients who experience PFS exhibit greater neurocognitive impairment, show little recovery over time, and decline further in some domains. Findings highlight the particularly high risk for long-term neurocognitive problems in patients who experience PFS and the need for close follow-up and intervention.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neuro Oncol

DOI

EISSN

1523-5866

Publication Date

November 29, 2017

Volume

19

Issue

12

Start / End Page

1673 / 1682

Location

England

Related Subject Headings

  • Syndrome
  • Survivors
  • Survival Rate
  • Prognosis
  • Postoperative Complications
  • Oncology & Carcinogenesis
  • Neuropsychological Tests
  • Medulloblastoma
  • Male
  • Infratentorial Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Schreiber, J. E., Palmer, S. L., Conklin, H. M., Mabbott, D. J., Swain, M. A., Bonner, M. J., … Gajjar, A. (2017). Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study. Neuro Oncol, 19(12), 1673–1682. https://doi.org/10.1093/neuonc/nox135
Schreiber, Jane E., Shawna L. Palmer, Heather M. Conklin, Donald J. Mabbott, Michelle A. Swain, Melanie J. Bonner, Mary L. Chapieski, Lu Huang, Hui Zhang, and Amar Gajjar. “Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study.Neuro Oncol 19, no. 12 (November 29, 2017): 1673–82. https://doi.org/10.1093/neuonc/nox135.
Schreiber JE, Palmer SL, Conklin HM, Mabbott DJ, Swain MA, Bonner MJ, et al. Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study. Neuro Oncol. 2017 Nov 29;19(12):1673–82.
Schreiber, Jane E., et al. “Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study.Neuro Oncol, vol. 19, no. 12, Nov. 2017, pp. 1673–82. Pubmed, doi:10.1093/neuonc/nox135.
Schreiber JE, Palmer SL, Conklin HM, Mabbott DJ, Swain MA, Bonner MJ, Chapieski ML, Huang L, Zhang H, Gajjar A. Posterior fossa syndrome and long-term neuropsychological outcomes among children treated for medulloblastoma on a multi-institutional, prospective study. Neuro Oncol. 2017 Nov 29;19(12):1673–1682.
Journal cover image

Published In

Neuro Oncol

DOI

EISSN

1523-5866

Publication Date

November 29, 2017

Volume

19

Issue

12

Start / End Page

1673 / 1682

Location

England

Related Subject Headings

  • Syndrome
  • Survivors
  • Survival Rate
  • Prognosis
  • Postoperative Complications
  • Oncology & Carcinogenesis
  • Neuropsychological Tests
  • Medulloblastoma
  • Male
  • Infratentorial Neoplasms